Isagani (Gani) M. Chico, M.D.

VP and Global Head for Oncology

Fortrea

Talk to Gani about these topics and more:

Oncology clinical trials (early phase to post approval)
Oncology medical affairs
Pharmaceutical, academic and regulatory interactions

Biostatistics

Cell and Gene (CGT)

Clinical Data

Clinical Strategic Planning

Clinical Trial Retention

Clinical Trial Supply

Clinical Trial Technology

Clinical Trials

Communication Strategies

Contract Research Organization (CRO)

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

FDA

Healthcare

Licensing Strategies

M.D.

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Research as Care

View Expert

Tracy Parker

Vice President, Biometrics

Advanced Clinical

Talk to Tracy about these topics and more:

Biometrics services implementation 
Customer relationship and strategic portfolio management 
Ensuring successful and quality-driven delivery in mixed-model/hybrid engagements 
Navigating data management in complex trial designs 
Diversity considerations in clinical research

View Expert

Tara Anne Kervin, MPH

VP Global Operations & Consulting

International Drug Development Institute (IDDI)

Talk to Tara about these topics and more:

Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
Best practices in clinical data science and biometrics operations
Clinical trial design and interim analysis
Biostatistical consulting and regulatory interaction

View Expert

Serge Bodart

Chief Commercial Officer

International Drug Development Institute (IDDI)

Talk to Serge about these topics and more:

Best practices on implementation of eCOA in clinical trials
Marketing in life sciences
How to select the CRO that best suits your clinical trial

View Expert

Cassandra Erato, MSN

Chief Executive Officer

Spaulding Clinical, LLC

Talk to Cassie about these topics and more:

Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct
Efficiencies and guidance in running Phase 1 of clinical development
Understanding cardiac safety requirements and the best cost-saving methods
Developing new service programs as needs emerge
Rapid operational scaling/growth, strategic planning, and recapitalization

View Expert